RESPIRATORY DISEASE CHRONIC

Clinical trials for RESPIRATORY DISEASE CHRONIC explained in plain language.

Never miss a new study

Get alerted when new RESPIRATORY DISEASE CHRONIC trials appear

Sign up with your email to follow new studies for RESPIRATORY DISEASE CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug fights common cold to protect vulnerable lungs

Disease control Completed

This study tested an experimental drug called vapendavir to see if it could reduce serious lung symptoms in people with COPD after they caught a common cold virus. Researchers gave the drug or a placebo to 52 adults with moderate COPD who were then exposed to the virus. The main …

Matched conditions: RESPIRATORY DISEASE CHRONIC

Phase: PHASE2 • Sponsor: Altesa Biosciences, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

RESPIRATORY DISEASE CHRONIC

Get alerted when new RESPIRATORY DISEASE CHRONIC trials appear

New drug fights common cold to protect vulnerable lungs